Abstract
EE574 Innovative Mechanisms of Pre-Market Authorization Access for Rare Diseases in Brazil. a Case Study of Pabinafusp-Alfa for Mucopolysaccharidosis Type II
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have